AYESHA HASSAN: Open Payments
NPI 1306305610 · MORGANTOWN, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 11 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $89 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Novo Nordisk Inc | 2 | $47 |
| Ascendis Pharma Endocrinology Inc | 1 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Insulet Corporation | 1 | $22 |
| KYOWA KIRIN, INC. | 1 | $18 |
| Sequel Med Tech, LLC | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: LEQVIO, Yorvipath, CRENESSITY, RECORLEV, Ozempic, Omnipod, CRYSVITA, TWIIST.
Industry payments across WV — which companies pay providers there.
